BioSpace News Archive

HALO Diagnostics, the leader in early disease detection using precision diagnostics, and Ikonopedia, a next-generation breast imaging reporting and tracking solution, today announced a genetic testing partnership to improve breast cancer detection and patient outcomes.

Heart Test Laboratories, Inc.d/b/a HeartSciences (NASDAQ: HSCS; HSCSW)(“HeartSciences” or the “Company”) today announced that Andrew Simpson, Chief Executive Officer of HeartSciences, will be presenting at the 2022 RHK Disruptive Growth Conference being held December 5-6, 2022 at the offices of Reed Smith in New York City.

Canon Medical Systems USA Inc. today announces the launch of SP Configurations, Orian SP and Galan SP.

Panbela Therapeutics, Inc today announced its first patients enrolled in Europe for its ASPIRE global clinical trial in the first-line treatment of metastatic pancreatic cancer.

Peptron, Inc. (KOSDAQ: 087010), a leading company in the development of peptide-based sustained-release drug products, announced on November 17 that it has successfully established bioequivalence of “PT105,” once-a-month injectable Leuprolide for the treatment of prostate cancer, breast cancer, endometriosis, and precocious puberty.

SK Life Science, Inc., a subsidiary of SK Biopharmaceuticals Co., Ltd., an innovative global pharmaceutical company focused on developing treatments for central nervous system (CNS) disorders, will present data on XCOPRI® (cenobamate tablets) CV, at the American Epilepsy Society (AES) Annual Meeting.

At the 64th Annual American Society of Hematology (ASH) Annual Meeting (December 10-13), The Leukemia & Lymphoma Society (LLS) will be presenting new research, leading sessions on the latest innovations in blood cancer treatment and equitable access to care, and proudly supporting hundreds of LLS-funded researchers who will share their findings.

Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced that David Fischel, Chairman and CEO, will participate in the Piper Sandler 34th Annual Healthcare Conference.

Blackford today announced their partnership to advance the real-time monitoring of AI performance with in-depth clinical intelligence.

Merit Medical Systems, Inc. (NASDAQ: MMSI), a leading global manufacturer and marketer of healthcare technology, today announced U.S. commercial release of the basixALPHA™ Inflation Device.